NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Esperion Therapeutics Inc (NASDAQ: ESPR)

 
ESPR Technical Analysis
4
As on 24th Dec 2024 ESPR STOCK Price closed @ 2.30 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.86 & Strong Buy for SHORT-TERM with Stoploss of 1.46 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ESPRSTOCK Price

Open 2.24 Change Price %
High 2.30 1 Day 0.06 2.68
Low 2.18 1 Week 0.05 2.22
Close 2.30 1 Month -0.22 -8.73
Volume 1955743 1 Year 0.79 52.32
52 Week High 3.83 | 52 Week Low 0.73
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
LMDX 0.02 0.00%
LCID 3.20 3.23%
AVGR 1.45 126.56%
NVDA 140.22 0.39%
AKTS 0.04 0.00%
TNXP 0.39 -2.50%
PONO 1.72 2.38%
TELL 1.00 0.00%
TSLA 462.28 7.36%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
GOEV 1.46 1725.00%
CLEU 2.63 1543.75%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
BAOS 8.24 390.48%
NDRAW 0.03 200.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
KPLTW 0.00 -100.00%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
TFFP 0.06 -62.50%
MILEW 0.06 -53.85%
MINM 0.15 -51.61%
LOTZW 0.01 -50.00%
 
 
ESPR
Daily Charts
ESPR
Intraday Charts
Whats New @
Bazaartrend
ESPR
Free Analysis
 
ESPR Important Levels Intraday
RESISTANCE2.53
RESISTANCE2.46
RESISTANCE2.41
RESISTANCE2.37
SUPPORT2.23
SUPPORT2.19
SUPPORT2.14
SUPPORT2.07
 
ESPR Forecast December 2024
4th UP Forecast4.17
3rd UP Forecast3.57
2nd UP Forecast3.2
1st UP Forecast2.83
1st DOWN Forecast1.77
2nd DOWN Forecast1.4
3rd DOWN Forecast1.03
4th DOWN Forecast0.43
 
ESPR Weekly Forecast
4th UP Forecast2.80
3rd UP Forecast2.64
2nd UP Forecast2.54
1st UP Forecast2.44
1st DOWN Forecast2.16
2nd DOWN Forecast2.06
3rd DOWN Forecast1.96
4th DOWN Forecast1.80
 
ESPR Forecast2024
4th UP Forecast8.54
3rd UP Forecast6.54
2nd UP Forecast5.3
1st UP Forecast4.07
1st DOWN Forecast0.53
2nd DOWN Forecast-0.7
3rd DOWN Forecast-1.94
4th DOWN Forecast-3.94
 
 
ESPR Other Details
Segment EQ
Market Capital 237180016.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ESPR Address
ESPR
 
ESPR Latest News
 
Your Comments and Response on Esperion Therapeutics Inc
 
ESPR Business Profile
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States and internationally. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. Address: 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service